FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892029609> ?p ?o ?g. }

• W2892029609 endingPage "779" @default.
• W2892029609 startingPage "767" @default.
• W2892029609 abstract "Clinical pharmacy services improve patient safety, outcomes, and care quality; however, UK clinical pharmacy services face limited resources, insufficient capacity, and patients who present with increasingly complex medication regimes and morbidities. These indicate a need for the prioritization of pharmacy services. Several prioritization tools have been developed; however, there has been no comprehensive review of such tools to date. A systematic review was conducted to provide a structured overview and description of existing assessment tools with a focus on study quality, themes, tool validity, risk factors, and high-risk drug classes. Systematic searches for English-language publications (from 1990 to September 2017) were conducted in Embase, Medline, Scopus, International Pharmaceutical Abstracts, and Web of Science. Papers in the inpatient setting and in which the tool users were pharmacists or pharmacy technicians were included. Data on each study (e.g. aim and design) and the structure of tools (e.g. risk factors) from each included study were extracted by 2 independent reviewers. A descriptive analysis was conducted to summarize these tools along with a thematic analysis of study findings. The quality of each paper was assessed using the Hawker method. Nineteen studies involving 17 risk assessment tools were included. Most tools were developed in Europe (76.5%) and published in the last 5 years (82%). Most tools (88%) were designed to identify patients at greatest risk of adverse drug reactions, adverse drug events, or medication errors and to guide appropriate pharmaceutical care. Ten out of 17 tools (59%) were validated. None showed a measurable impact on prescription errors or adverse drug events. Keys themes identified from the studies were the positive impact of risk assessment tools on both patient care and provision of pharmacy services as well as the limitations of risk assessment tools. Current assessment tools are heterogeneous in their content, targeting diverse patient groups and clinical settings making generalization difficult. However, an underlying theme of all studies was that tools appear to achieve their aim in directing pharmaceutical care to where it is needed most which might provide reassurance and incentive for greater adoption and development of tools across clinical pharmacy services. However, further research is required to measure objectively the impact of tools on patient outcomes and on workforce efficiency so that comparisons can be made between tools." @default.
• W2892029609 created "2018-09-27" @default.
• W2892029609 creator A5003988625 @default.
• W2892029609 creator A5042293747 @default.
• W2892029609 creator A5062928635 @default.
• W2892029609 date "2019-06-01" @default.
• W2892029609 modified "2023-10-14" @default.
• W2892029609 title "Patient prioritization for pharmaceutical care in hospital: A systematic review of assessment tools" @default.
• W2892029609 cites W1493237957 @default.
• W2892029609 cites W1536069729 @default.
• W2892029609 cites W1917439754 @default.
• W2892029609 cites W1976770755 @default.
• W2892029609 cites W1991283062 @default.
• W2892029609 cites W1991405190 @default.
• W2892029609 cites W1991864978 @default.
• W2892029609 cites W1992746042 @default.
• W2892029609 cites W1993053792 @default.
• W2892029609 cites W1996401140 @default.
• W2892029609 cites W2010360657 @default.
• W2892029609 cites W2024620182 @default.
• W2892029609 cites W2030775318 @default.
• W2892029609 cites W2034133734 @default.
• W2892029609 cites W2045930722 @default.
• W2892029609 cites W2048559676 @default.
• W2892029609 cites W2052084025 @default.
• W2892029609 cites W2079560112 @default.
• W2892029609 cites W2084980263 @default.
• W2892029609 cites W2104471440 @default.
• W2892029609 cites W2121927413 @default.
• W2892029609 cites W2132194125 @default.
• W2892029609 cites W2146030020 @default.
• W2892029609 cites W2148554860 @default.
• W2892029609 cites W2153448880 @default.
• W2892029609 cites W2163917039 @default.
• W2892029609 cites W2297358211 @default.
• W2892029609 cites W2412642468 @default.
• W2892029609 cites W2417455421 @default.
• W2892029609 cites W2476443865 @default.
• W2892029609 cites W2511327249 @default.
• W2892029609 cites W2563920103 @default.
• W2892029609 cites W2589439632 @default.
• W2892029609 cites W2616030833 @default.
• W2892029609 cites W2761453986 @default.
• W2892029609 cites W2767069004 @default.
• W2892029609 cites W2780979005 @default.
• W2892029609 cites W4294215472 @default.
• W2892029609 cites W4378951071 @default.
• W2892029609 doi "https://doi.org/10.1016/j.sapharm.2018.09.009" @default.
• W2892029609 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30268841" @default.
• W2892029609 hasPublicationYear "2019" @default.
• W2892029609 type Work @default.
• W2892029609 sameAs 2892029609 @default.
• W2892029609 citedByCount "27" @default.
• W2892029609 countsByYear W28920296092019 @default.
• W2892029609 countsByYear W28920296092020 @default.
• W2892029609 countsByYear W28920296092021 @default.
• W2892029609 countsByYear W28920296092022 @default.
• W2892029609 countsByYear W28920296092023 @default.
• W2892029609 crossrefType "journal-article" @default.
• W2892029609 hasAuthorship W2892029609A5003988625 @default.
• W2892029609 hasAuthorship W2892029609A5042293747 @default.
• W2892029609 hasAuthorship W2892029609A5062928635 @default.
• W2892029609 hasBestOaLocation W28920296092 @default.
• W2892029609 hasConcept C104863432 @default.
• W2892029609 hasConcept C111472728 @default.
• W2892029609 hasConcept C129930760 @default.
• W2892029609 hasConcept C138885662 @default.
• W2892029609 hasConcept C144024400 @default.
• W2892029609 hasConcept C144133560 @default.
• W2892029609 hasConcept C159110408 @default.
• W2892029609 hasConcept C160735492 @default.
• W2892029609 hasConcept C162324750 @default.
• W2892029609 hasConcept C17744445 @default.
• W2892029609 hasConcept C190248442 @default.
• W2892029609 hasConcept C195094911 @default.
• W2892029609 hasConcept C199539241 @default.
• W2892029609 hasConcept C2426938 @default.
• W2892029609 hasConcept C2777615720 @default.
• W2892029609 hasConcept C2779328685 @default.
• W2892029609 hasConcept C2779473830 @default.
• W2892029609 hasConcept C2779530757 @default.
• W2892029609 hasConcept C36289849 @default.
• W2892029609 hasConcept C50522688 @default.
• W2892029609 hasConcept C512399662 @default.
• W2892029609 hasConcept C71924100 @default.
• W2892029609 hasConcept C74196892 @default.
• W2892029609 hasConcept C83867959 @default.
• W2892029609 hasConceptScore W2892029609C104863432 @default.
• W2892029609 hasConceptScore W2892029609C111472728 @default.
• W2892029609 hasConceptScore W2892029609C129930760 @default.
• W2892029609 hasConceptScore W2892029609C138885662 @default.
• W2892029609 hasConceptScore W2892029609C144024400 @default.
• W2892029609 hasConceptScore W2892029609C144133560 @default.
• W2892029609 hasConceptScore W2892029609C159110408 @default.
• W2892029609 hasConceptScore W2892029609C160735492 @default.
• W2892029609 hasConceptScore W2892029609C162324750 @default.
• W2892029609 hasConceptScore W2892029609C17744445 @default.
• W2892029609 hasConceptScore W2892029609C190248442 @default.

• next